Search Result
Results for "
N-oxidation
" in MedChemExpress (MCE) Product Catalog:
3
Biochemical Assay Reagents
51
Isotope-Labeled Compounds
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-116084
-
-
-
- HY-116084S
-
-
-
- HY-Y1101B
-
|
N-Methylmorpholine N-Oxide; MMNO; 4-Methylmorpholine 4-oxide
|
Biochemical Assay Reagents
|
Others
|
|
4-Methylmorpholine N-oxide (N-Methylmorpholine N-Oxide; MMNO; 4-Methylmorpholine 4-oxide) is an amine oxide ligand and ozonation reagent. 4-Methylmorpholine N-oxide forms coordination complexes with lanthanum (III) nitrate and yttrium (III) nitrate via its nitroso oxygen atom. The metal-ligand bonds are dominated by electrostatic interactions with a small covalent component. 4-Methylmorpholine N-oxide is applicable in ozonation reactions for the synthesis of methyl 9-oxononanoate .
|
-
-
- HY-108915
-
-
-
- HY-125785A
-
|
|
Bacterial
|
Infection
|
|
2-Mercaptopyridine N-oxide sodium has bactericidal effect and is against a standard strain of Mycobacterium tuberculosis H37Rv (ATCC 27294) with MIC90 of 7.20 μM. 2-Mercaptopyridine N-oxide sodium and its complex with iron, gallium, and bismuth have good anti-M. tuberculosis activity. 2-Mercaptopyridine N-oxide sodium has potential for the treatment of tuberculosis .
|
-
-
- HY-124098
-
|
Lidocaine N-oxide
|
Drug Metabolite
|
Others
|
|
Lignocaine N-oxide (Lidocaine N-oxide) is a compound derived from the metabolism of lidocaine. Lidocaine can be metabolized to its N-oxide in rat liver microsomes.
|
-
-
- HY-142122
-
|
|
Drug Metabolite
|
Neurological Disease
|
|
Imipramine N-oxide is the metabolite of Imipramine. Imipramine N-oxide exhibits low toxicity in rat and mouse experiments. Imipramine N-oxide can be used for the research of endogenous depressions .
|
-
-
- HY-N1402
-
|
Sophoridine N-oxide
|
Apoptosis
|
Inflammation/Immunology
|
|
Oxysophoridine (Sophoridine N-oxide) is a bioactive alkaloid extracted from the Sophora alopecuroides Linn. Oxysophoridine (Sophoridine N-oxide) shows anti inflammatory, anti oxidative stress and anti apoptosis effects .
|
-
-
- HY-119393
-
|
|
Drug Metabolite
|
Others
|
|
Olanzapine N-oxide is a compound under investigation for the metabolism of antipsychotic compounds. Olanzapine N-oxidation and N-demethylation are catalyzed by different enzymes, and its plasma concentration and clearance are not affected by a single factor, such as a specific genotype or smoking behavior.
|
-
-
- HY-W145090
-
|
p-Dimethylaminopyridine N-oxide
|
Biochemical Assay Reagents
|
Others
|
|
4-Dimethylaminopyridine N-oxide (p-Dimethylaminopyridine N-oxide) is an Efficient Oxidizing Agent for Alkyl Halides .
|
-
-
- HY-17366R
-
|
|
Reference Standards
mAChR
Dopamine Receptor
Drug Metabolite
|
Neurological Disease
|
|
Clozapine N-oxide (Standard) is the analytical standard of Clozapine N-oxide. This product is intended for research and analytical applications. Clozapine N-oxide is a major metabolite of Clozapine and a human muscarinic designer receptors (DREADDs) agonist. Clozapine N-oxide activates the DREADD receptor hM3Dq and hM4Di. Clozapine N-oxide cannot cross the blood-brain barrier[1][2][3][4]. Clozapine is a potent dopamine antagonist and also a potent and selective muscarinic M4 receptor (EC50=11 nM) agonist[5][6].
|
-
-
- HY-137989A
-
|
Voriconazole oxynitride hydrochloride
|
Drug Metabolite
|
Infection
|
|
Voriconazole N-oxide (Voriconazole oxynitride) (hydrochloride) is the main metabolite of Voriconazole (HY-76200) , a widely used triazole antibiotic (fungal). Voriconazole N-oxide (hydrochloride) provides information on the patient's drug metabolism capacity .
|
-
-
- HY-N6637S
-
|
|
Isotope-Labeled Compounds
|
Cancer
|
|
Senecionine N-oxide-d3 is the deuterium labeled Senecionine N-oxide. Senecionine n-oxide is the primary product of pyrrolizidine alkaloid biosynthesis in root cultures of Senecio vulgaris. Senecionine N-oxide has anti-cancer activity .
|
-
-
- HY-116084S1
-
-
-
- HY-N11425
-
|
|
Others
|
Others
|
|
Benzydamine N-Oxide is a metabolite of Benzydamine. Benzydamine N-Oxide can be used to measure flavin-containing monooxygenase activity .
|
-
-
- HY-133798
-
|
|
Cytochrome P450
Drug Metabolite
|
Cancer
|
|
Sorafenib N-oxide is an active metabolite of sorafenib (HY-10201). Sorafenib N-oxide is a linear-mixed inhibitor of microsomal CYP3A4, with a Ki of 15 μM .
|
-
-
- HY-100639R
-
-
-
- HY-133724
-
-
-
- HY-141773S
-
-
-
- HY-133794S
-
|
|
Isotope-Labeled Compounds
Drug Metabolite
|
Cancer
|
|
Dasatinib N-oxide-d8 is the deuterium labeled Dasatinib N-oxide. Dasatinib N-oxide is a minor metabolite of Dasatinib. Dasatinib is a potent and orally active dual Src/Bcr-Abl inhibitor .
|
-
-
- HY-135265
-
|
Ro 12-5637
|
Monoamine Oxidase
|
Neurological Disease
|
|
Moclobemide N-Oxide (Ro 12-5637) is N-oxide metabolite of Moclobemide. Moclobemide N-Oxide retains certain MAO-A (monoamine oxidase) inhibitory activity, but is generally present in low concentrations. Moclobemide N-Oxide can be detected by UV absorption at 240 nm .
|
-
-
- HY-W700973S
-
-
-
- HY-137989
-
|
Voriconazole oxynitride
|
Fungal
|
Infection
|
|
Voriconazole N-oxide (Voriconazole oxynitride) is a potent antifungal agent. Voriconazole N-oxide has phototoxicity and photocarcinogenicity. Voriconazole N-oxide does not sensitize keratinocytes to ultraviolet B (UVB) .
|
-
-
- HY-101407R
-
-
-
- HY-146481S
-
-
-
- HY-133590
-
|
|
DNA Alkylator/Crosslinker
|
Cancer
|
|
Heliotrine N-oxide is the corresponding PA (pyrrolizidine alkaloid) N-oxide of Heliotrine (HY-126128). Heliotrine N-oxide leads to the formation of pyrrolic DNA adducts and potential initiation of PA-induced liver tumors in vivo .
|
-
-
- HY-116084R
-
-
-
- HY-138199S
-
-
-
- HY-100636
-
|
|
EGFR
|
Cancer
|
|
Gefitinib N-oxide is the N-oxide derivative of Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells .
|
-
-
- HY-151241
-
|
(+)-Sinomenine N-oxide
|
NO Synthase
|
Inflammation/Immunology
|
|
Sinomenine N-oxide has anti-angiogenic, anti-inflammatory and anti-rheumatic effects. Sinomenine N-oxide is also a NO production inhibitor, with an IC50 value of 23.04 μM .
|
-
-
- HY-147085
-
-
-
- HY-116832
-
|
|
NO Synthase
|
Cancer
|
|
Retrorsine N-oxide, an N-oxide of pyrrolizidine alkaloid, is a carcinogen. Retrorsine N-oxide-derived DNA adducts are common toxicological biomarkers of pyrrolizidine alkaloid N-oxides .
|
-
-
- HY-133724R
-
-
-
- HY-N9512S
-
|
|
Isotope-Labeled Compounds
|
Others
|
|
Lycopsamine N-oxide-d3 is the deuterium labeled Lycopsamine N-oxide. Lycopsamine N-oxide, an N-oxide of Lycopsamine which is a pyrrolizidine alkaloid, can be found in honey and bee pollen .
|
-
-
- HY-137989S
-
|
Voriconazole oxynitride-d3
|
Isotope-Labeled Compounds
Fungal
|
Infection
|
|
Voriconazole N-oxide-d3 (Voriconazole oxynitride-d3) is deuterium labeled Voriconazole N-oxide. Voriconazole N-oxide (Voriconazole oxynitride) is a potent antifungal agent. Voriconazole N-oxide has phototoxicity and photocarcinogenicity. Voriconazole N-oxide does not sensitize keratinocytes to ultraviolet B (UVB) .
|
-
-
- HY-N15707
-
|
(+)-Isocorydine N-oxide
|
Cholinesterase (ChE)
|
Neurological Disease
|
|
Isocorydine N-oxide ((+)-Isocorydine N-oxide), an alkaloidal, a acetylcholinesterase (AChE) inhibitor. Isocorydine N-oxide can be used for the study of Alzheimer's disease .
|
-
-
- HY-B1061R
-
|
|
Drug Derivative
Reference Standards
|
Cardiovascular Disease
|
|
Nicotinic acid N-oxide (Standard) is the analytical standard of Nicotinic acid N-oxide. This product is intended for research and analytical applications. Nicotinic acid N-oxide can be used for research on hyperlipidemia.
|
-
-
- HY-N2561
-
|
|
Others
|
Cancer
|
|
Seneciphylline N-Oxide is a dehydrogenation product of Senecionine N-oxide. Seneciphylline N-Oxide is a natural compound isolated from root cultures of Senecio erucifolius (Asteraceae) .
|
-
-
- HY-N16472
-
|
|
Endogenous Metabolite
|
Others
|
|
Echiumine N-oxide, a pyrrolizidine alkaloid related N-oxides (PANOs), is a plant secondary metabolite. Echiumine N-oxide can be isolated from Echium plantagineum. Echiumine N-oxide acts as a defensive role in plants, prevent plants from tissue death .
|
-
-
- HY-100644
-
|
Trimethoprim 1-N-oxide
|
Drug Metabolite
|
Infection
|
|
Trimethoprim N-oxide (Trimethoprim 1-N-oxide) belongs to human urinary metabolites. Trimethoprim N-oxide is generated by oxidation of nitrogen atoms in the pyrimidine ring. Trimethoprim N-oxide is formed predominantly by CYP1A2 in human liver microsomes .
|
-
-
- HY-135586R
-
|
|
Reference Standards
Drug Metabolite
|
Metabolic Disease
|
|
Raloxifene N-Oxide (Standard) is the analytical standard of Raloxifene N-Oxide. This product is intended for research and analytical applications. Raloxifene N-Oxide is a Raloxifene oxidative degradation product .
|
-
-
- HY-W740127
-
-
-
- HY-134137S
-
-
-
- HY-N6828R
-
|
|
Reference Standards
Others
|
Metabolic Disease
|
|
Monocrotaline N-Oxide (Standard) is the analytical standard of Monocrotaline N-Oxide. This product is intended for research and analytical applications. Monocrotaline N-Oxide, a monocrotaline metabolite, leads to DNA adduct formation in vivo .
|
-
-
- HY-N2561AR
-
|
|
Reference Standards
Others
|
Others
|
|
Spartioidine N-oxide (Standard) is the analytical standard of Spartioidine N-oxide. This product is intended for research and analytical applications. Spartioidine N-oxide is a pyrrolizidine alkaloid and can be isolated from Senecio vulgaris .
|
-
-
- HY-W769381
-
-
-
- HY-144239S
-
-
-
- HY-135740S
-
-
-
- HY-W701397
-
-
-
- HY-148377
-
|
|
Drug Metabolite
|
Cancer
|
|
Abiraterone sulfate N-oxide is a carboxylic acid. Abiraterone sulfate N-oxide also is a major metabolite of Abiraterone (HY-70013). Abiraterone sulfate N-oxide can be used for the research of prostate cancer .
|
-
- HY-N6827R
-
|
|
Reference Standards
Others
|
Inflammation/Immunology
|
|
Usaramine N-oxide (Standard) is the analytical standard of Usaramine N-oxide. This product is intended for research and analytical applications. Usaramine N-oxide, a alkaloid isolated from Crotalaria pallida, possesses anti-inflammatory activities .
|
-
- HY-W709612
-
|
N-Desmethyl regorafenib N-oxide-d3-1
|
Isotope-Labeled Compounds
VEGFR
Raf
c-Kit
Drug Metabolite
|
Cancer
|
|
Regorafenib N-oxide and N-desmethyl (M5)-d3-1 (N-Desmethyl regorafenib N-oxide-d3-1) is the deuterium labeled Regorafenib N-oxide and N-desmethyl (M5) (HY-108226). Regorafenib N-oxide and N-desmethyl (M5) (N-Desmethyl regorafenib N-oxide) is an active metabolite of Sorafenib (HY-10201) and can be metabolized by CYP3A4 .
|
-
- HY-G0011S
-
-
- HY-138199S1
-
-
- HY-N16468
-
-
- HY-W753452
-
-
- HY-W739718
-
-
- HY-N9512
-
|
|
Others
|
Others
|
|
Lycopsamine N-oxide, an N-oxide of Lycopsamine which is a pyrrolizidine alkaloid, can be found in honey and bee pollen .
|
-
- HY-133787R
-
|
|
Reference Standards
Drug Metabolite
|
Infection
|
|
Levofloxacin N-oxide (Standard) is the analytical standard of Levofloxacin N-oxide. This product is intended for research and analytical applications. Levofloxacin N-oxide is a minor metabolite of Levofloxacin (HY-B0330). Levofloxacin N-oxide does not exhibit significantly genotoxic risks. Levofloxacin is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria .
|
-
- HY-142440S
-
-
- HY-158815
-
|
Lipid H N-Oxide; LNP-102 N-Oxide
|
Drug Derivative
|
Infection
|
|
SM-102 N-oxide (Lipid H N-Oxide) is an impurity of SM-102 (HY-134541).
|
-
- HY-W707957
-
|
|
Drug Intermediate
|
Cancer
|
|
Intermedine N-oxide is a pyrrolizidine alkaloid indicine that can be found in Crotalaria spectabilis. Intermedine N-oxide shows anticancer activity .
|
-
- HY-W715183
-
-
- HY-N9511
-
|
|
Others
|
Others
|
|
Jacobine N-oxide, an N-oxide of Jacobine which is a pyrrolizidine alkaloid, can be found in Senecio hybrids that has thrips resistance .
|
-
- HY-108915R
-
-
- HY-W748582
-
|
|
Isotope-Labeled Compounds
Dopamine Receptor
mAChR
Drug Metabolite
|
Neurological Disease
|
|
Clozapine N-oxide-d8 is the deuterium labeled Clozapine N-oxide (HY-17366). Clozapine N-oxide is a major metabolite of Clozapine and a human muscarinic designer receptors (DREADDs) agonist. Clozapine N-oxide activates the DREADD receptor hM3Dq and hM4Di. Clozapine N-oxide can't cross the blood-brain barrier . Clozapine is a potent dopamine antagonist and also a potent and selective muscarinic M4 receptor (EC50=11 nM) agonist .
|
-
- HY-17366AR
-
|
|
Reference Standards
mAChR
Dopamine Receptor
Drug Metabolite
|
Neurological Disease
|
|
Clozapine N-oxide (dihydrochloride) (Standard) is the analytical standard of Clozapine N-oxide (dihydrochloride). This product is intended for research and analytical applications. Clozapine N-oxide dihydrochloride is a major metabolite of Clozapine and a human muscarinic designer receptors (DREADDs) agonist. Clozapine N-oxide dihydrochloride activates the DREADD receptor hM3Dq and hM4Di. Clozapine N-oxide dihydrochloride can cross the blood-brain barrier[1][2][3][4]. Clozapine is a potent dopamine antagonist and also a potent and selective muscarinic M4 receptor (EC50=11 nM) agonist[5][6].
|
-
- HY-N14959
-
|
|
Antibiotic
Bacterial
|
Infection
Cancer
|
|
Deacetylravidomycin N-oxide is an antibiotic that can be produced by Streptomyces ravidus S50905. Deacetylravidomycin N-oxide is active against Gram-positive bacteria but inactive against Gram-negative bacteria. Deacetylravidomycin N-oxide has antitumor activity against P388 leukemia and methamphetamine A fibrosarcoma .
|
-
- HY-N6848
-
|
|
Drug Derivative
|
Infection
|
|
Acetylseneciphylline N-oxide is a pyrrolizine alkaloid that is seneciphylline in which the hydroxy hydrogen is replaced by an acetyl group and the tertiary amino function is oxidised to the corresponding N-oxide .
|
-
- HY-100664
-
-
- HY-131574
-
|
|
mAChR
|
Neurological Disease
|
|
Heliosupine N-oxide, Heliosupin metabolite, inhibits muscarinic acetylcholine receptor (mAChR) with the IC50 of 350 μM. Heliosupine N-oxide is a pyrrolizidine alkaloid (PA) .
|
-
- HY-W722562
-
|
|
Reactive Oxygen Species (ROS)
|
Inflammation/Immunology
|
|
Trimethylamine oxide- 15N is the deuterium labeled Trimethylamine N-oxide (HY-116084). Trimethylamine N-oxide is a gut microbe-dependent metabolite of dietary choline and other trimethylamine-containing nutrients. Trimethylamine N-oxide induces inflammation by activating the ROS/NLRP3 inflammasome. Trimethylamine N-oxide also accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis by activating the TGF-β/smad2 signaling pathway .
|
-
- HY-N6637
-
|
|
Others
|
Cancer
|
|
Senecionine n-oxide is the primary product of pyrrolizidine alkaloid biosynthesis in root cultures of Senecio vulgaris. Senecionine N-oxide has anti-cancer activity .
|
-
- HY-108226S
-
|
N-Desmethyl regorafenib N-oxide-d3
|
Isotope-Labeled Compounds
|
Others
|
|
Regorafenib N-oxide and N-desmethyl (M5)-d3 is deuterium labeled Regorafenib N-oxide and N-desmethyl (M5).
|
-
- HY-100636A
-
|
|
EGFR
|
Cancer
|
|
Gefitinib N-oxide hydrochloride is the N-oxide derivative of Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells .
|
-
- HY-N7263
-
|
|
Cholinesterase (ChE)
|
Neurological Disease
|
|
Galanthamine N-Oxide is an alkaloid obtained from the bulbs of Zephyranthes concolor. Galanthamine N-Oxide inhibits electric eel acetylcholinesterase (AChE) with an EC50 of 26.2 μM. Galanthamine N-Oxide is a prominent inhibitor of substrate accommodation in the active site of the Torpedo californica AChE (TcAChE), hAChE and hBChE enzymes .
|
-
- HY-108226S1
-
-
- HY-108226
-
|
N-Desmethyl regorafenib N-oxide
|
Drug Metabolite
Raf
VEGFR
c-Kit
|
Cancer
|
|
Regorafenib N-oxide and N-desmethyl (M5) (N-Desmethyl regorafenib N-oxide) is an active metabolite of Sorafenib (HY-10201) and can be metabolized by CYP3A4 .
|
-
- HY-Z8410
-
-
- HY-W653822
-
|
(2S)-Nicotine 1-N-oxide
|
Drug Metabolite
|
Others
|
|
(2'S)-Nicotine 1-oxide ((2S)-Nicotine 1-N-oxide) is an alkaloid N-oxide, which is found in leaves, stems and roots of Nicotiana tabacum .
|
-
- HY-Z2493
-
|
|
Dopamine Receptor
|
Neurological Disease
|
|
Aripiprazole N-oxide is a metabolite of the atypical antipsychotic Aripiprazole (HY-14546). Aripiprazole N-oxide is formed from aripiprazole by the cytochrome P450 (CYP) isoforms CYP2D6 and CYP3A4.
|
-
- HY-W698938
-
-
- HY-W703386
-
-
- HY-133786S
-
-
- HY-W710291
-
-
- HY-119393S
-
-
- HY-132447S
-
-
- HY-141783S
-
-
- HY-133797S
-
-
- HY-133792S
-
-
- HY-105389
-
|
RWJ-38705
|
Opioid Receptor
|
Neurological Disease
|
|
Tramadol N-oxide (RWJ 38705) is an analgesic. Tramadol N-oxide sproduces dose-related, long-lasting antinociception. Tramadol N-oxide has affinity for μ opioid receptor (Ki = 38.5 μM) and δ, κ receptors (Ki > 100 μM). Tramadol N-oxide can be used for the study of analgesic effect .
|
-
- HY-142122R
-
|
|
Reference Standards
Drug Metabolite
|
Neurological Disease
|
|
Imipramine N-oxide (Standard) is the analytical standard of Imipramine N-oxide. This product is intended for research and analytical applications. Imipramine N-oxide is the metabolite of Imipramine. Imipramine is a tertiary amine tricyclic antidepressant[1][2].
|
-
- HY-100067R
-
|
|
Reference Standards
|
|
|
Quetiapine N-oxide (Standard) is the analytical standard of Quetiapine N-oxide. This product is intended for research and analytical applications.
|
-
- HY-I0194R
-
|
|
Reference Standards
|
|
|
Cinacalcet N-Oxide (Standard) is the analytical standard of Cinacalcet N-Oxide. This product is intended for research and analytical applications.
|
-
- HY-W087967S
-
-
- HY-132343S
-
|
|
Isotope-Labeled Compounds
|
Neurological Disease
|
|
Zolmitriptan N-Oxide-d6 is a deuterium labeled Zolmitriptan N-Oxide. Zolmitriptan N-Oxide is the major metabolite of Zolmitriptan. Zolmitriptan is a 5-HT1B/1D receptor partial agonist .
|
-
- HY-N17527
-
|
|
Others
|
Infection
|
|
7-Demethoxytylophorine N-oxide is an alkaloid inhibitor of Tobacco Mosaic Virus. 7-Demethoxytylophorine N-oxide can be isolated from the aerial parts of Cynanchum komarovii. 7-Demethoxytylophorine N-oxide is applicable to research related to Tobacco Mosaic Virus infection .
|
-
- HY-W770773
-
|
|
Drug Derivative
|
Cancer
|
|
Bosutinib N-Oxide (Compound 80) is a quinoline-type heterocyclic compound. Bosutinib N-Oxide shows anti-proliferative activity and can be used for research of leukemia .
|
-
- HY-133727
-
|
|
Histamine Receptor
Potassium Channel
|
Cardiovascular Disease
Inflammation/Immunology
|
|
Terfenadine N-oxide, an N-oxide derivative of Terfenadine (HY-B1193), is a histamine H1 receptor antagonist (IC50 = 2.73 μM) and an hERG potassium channel inhibitor (IC50 = 0.698 μM). Terfenadine N-oxide is can be used for the research of histamine-related allergic diseases and hERG channel-associated arrhythmias .
|
-
- HY-N17304
-
|
|
Drug Derivative
P-glycoprotein
|
Cancer
|
|
10S,13aR-Antofine N-oxide is a phenanthroindolizidine N-oxide alkaloid and cytotoxic agent found in Cynanchum vincetoxicum. 10S,13aR-Antofine N-oxide exerts cytotoxic effects in drug-sensitive (KB-3-1, IC50 = 0.11 μM) and multi-drug-resistant (KB-V1, IC50 = 0.16 μM) carcinoma cells. 10S, 13aR-Antofine N-oxide acts as a poor substrate for the P-glycoprotein (P-170) efflux pump. 10S,13aR-Antofine N-oxide can be used for the research of cancers .
|
-
- HY-100639
-
-
- HY-B1061
-
-
- HY-131587
-
|
|
Others
|
Others
|
|
Integerrimine N-oxide, the main pyrrolizidine alkaloid found in the butanolic residue (BR) of Senecio brasiliensis. Prenatal exposure to integerrimine N-oxide induces maternal toxicity, impairment of maternal care and delays in physical and behavioral development of the offspring .
|
-
- HY-147333
-
|
|
Drug Metabolite
|
Neurological Disease
|
|
Trimipramine N-oxide is an active metabolite of the tricyclic antidepressant trimipramine. Trimipramine N-oxide inhibits the human monoamine transporters for noradrenaline (hNAT), serotonin (hSERT), dopamine (hDAT) and the human organic cation transporters (hOCT1 and hOCT2) with IC50s of 11.7, 3.59, 9.4, 9.35 and 27.4 nM, respectively. Trimipramine N-oxide can be used for the research of depression and anxiety .
|
-
- HY-W539799
-
|
2,6-Dimethylpyridine N-oxide
|
Biochemical Assay Reagents
|
Others
|
|
2,6-Lutidine N-oxide (2,6-Dimethylpyridine N-oxide) is a plant growth regulator that can improve the initial growth of plants and increase early yield and total yield. Lutidine is the dimethyl derivative of pyridine .
|
-
- HY-135586
-
-
- HY-133785
-
|
Ropinirole N-oxide
|
Drug Intermediate
|
Others
|
|
Ropinirole impurity 4 (Ropinirole N-oxide) is an impurity of Ropinirole.
|
-
- HY-Z8635
-
|
Hydroxychloroquine N-Oxide
|
Drug Intermediate
|
Others
|
|
Hydroxychloroquine impurity 1 (Hydroxychloroquine N-Oxide) is an impurity of Hydroxychloroquine.
|
-
- HY-Z12469
-
|
Rivastigmine N-oxide
|
Drug Intermediate
|
Others
|
|
Rivastigmine impurity 6 (Rivastigmine N-oxide) is an impurity of Rivastigmine.
|
-
- HY-W436573
-
|
Paliperidone N-oxide
|
Drug Intermediate
|
Others
|
|
Paliperidone impurity 12 (Paliperidone N-oxide) is an impurity of Paliperidone.
|
-
- HY-Z4525
-
-
- HY-W177986
-
-
- HY-W718461
-
|
Trimetazidine N-oxide dihydrochloride
|
Drug Intermediate
|
Others
|
|
Trimetazidine impurity 1 dihydrochloride (Trimetazidine N-oxide dihydrochloride) is an impurity of Trimetazidine dihydrochloride.
|
-
- HY-114202
-
-
- HY-Z19622
-
|
Amiodarone N-oxide
|
Drug Intermediate
|
Others
|
|
Amiodarone impurity 1 (Amiodarone N-oxide) is an impurity of Amiodarone.
|
-
- HY-136486
-
|
|
Others
|
Cancer
|
|
Lasiocarpine N-oxide is a natural compound with antitumor activity .
|
-
- HY-Z19678
-
|
Haloperidol N-oxide
|
Drug Intermediate
|
Others
|
|
Haloperidol impurity 7 (Haloperidol N-oxide) is an impurity of Haloperidol.
|
-
- HY-W654357
-
|
Terbinafine N-oxide
|
Drug Intermediate
|
Others
|
|
Terbinafine impurity 6 (Terbinafine N-oxide) is an impurity of Terbinafine.
|
-
- HY-Z7660
-
|
|
Drug Metabolite
|
Metabolic Disease
Inflammation/Immunology
|
|
Lansoprazole N-oxide (Comound 2) is the overoxidized by-product found in the synthesis of the proton pump inhibitor Lansoprazole (HY-13662). Lansoprazole N-oxide is promising for research of duodenal and gastric ulcers, reflux oesophagitis, and Zollinger–Ellison syndrome .
|
-
- HY-17366A
-
|
|
mAChR
Dopamine Receptor
Drug Metabolite
|
Neurological Disease
|
|
Clozapine N-oxide dihydrochloride is a major metabolite of Clozapine and a human muscarinic designer receptors (DREADDs) agonist. Clozapine N-oxide dihydrochloride activates the DREADD receptor hM3Dq and hM4Di. Clozapine N-oxide dihydrochloride cannot cross the blood-brain barrier . Clozapine is a potent dopamine antagonist and also a potent and selective muscarinic M4 receptor (EC50=11 nM) agonist .
|
-
- HY-17366
-
|
|
Drug Metabolite
mAChR
Dopamine Receptor
|
Neurological Disease
|
|
Clozapine N-oxide is a major metabolite of Clozapine and a human muscarinic designer receptors (DREADDs) agonist. Clozapine N-oxide activates the DREADD receptor hM3Dq and hM4Di. Clozapine N-oxide can't cross the blood-brain barrier . Clozapine is a potent dopamine antagonist and also a potent and selective muscarinic M4 receptor (EC50=11 nM) agonist .
|
-
- HY-133787
-
|
|
Drug Metabolite
|
Infection
|
|
Levofloxacin N-oxide is a minor metabolite of Levofloxacin (HY-B0330). Levofloxacin N-oxide does not exhibit significantly genotoxic risks. Levofloxacin is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria .
|
-
- HY-182195
-
|
|
Drug Derivative
Sodium Channel
|
Neurological Disease
|
|
Suzetrigine N-oxide (the third compound in P57) is a derivative of Suzetrigine (HY-148800). Suzetrigine N-oxide is an inhibitor of voltage-gated sodium channels (Nav1.8) and can be used for research on the treatment of pain, especially neuropathic pain .
|
-
- HY-N7774
-
|
|
Others
|
Others
|
|
Echinatine N-oxide is a pyrrolizidine alkaloid found in R. graeca .
|
-
- HY-133010
-
-
- HY-W653765
-
|
(S)-Citalopram N-oxide
|
Drug Intermediate
|
Others
|
|
Escitalopram impurity 2 ((S)-Citalopram N-oxide) is an impurity of Escitalopram.
|
-
- HY-W701756
-
|
Ranolazine bis(N-oxide)
|
Drug Intermediate
|
Others
|
|
Ranolazine impurity 1 (Ranolazine bis(N-oxide)) is an impurity of Ranolazine.
|
-
- HY-Z7659
-
|
|
Drug Metabolite
|
Metabolic Disease
Inflammation/Immunology
|
|
Lansoprazole sulfone N-Oxide (Comound 3) is the overoxidized by-product found in the synthesis of the proton pump inhibitor Lansoprazole (HY-13662). Lansoprazole sulfone N-Oxide is promising for research of duodenal and gastric ulcers, reflux oesophagitis, and Zollinger–Ellison syndrome .
|
-
- HY-Z2332
-
|
Azithromycin 3'-N-oxide
|
Drug Intermediate
|
Others
|
|
Azithromycin impurity 17 (Azithromycin 3'-N-oxide) is an impurity of Azithromycin.
|
-
- HY-Z14907A
-
|
Donepezil alkene pyridine N-oxide
|
Drug Intermediate
|
Others
|
|
Donepezil impurity 4 (Donepezil alkene pyridine N-oxide) is an impurity of Donepezil.
|
-
- HY-N3105
-
|
Longistylumphylline A N-oxide
|
Others
|
Others
|
|
Paxiphylline D (Longistylumphylline A N-oxide) is a product that can be isolated from .
|
-
- HY-W576312
-
-
- HY-N13343
-
|
|
Others
|
Others
|
|
1-Methoxycarbonyl-beta-carboline-N-oxide is a natural product .
|
-
- HY-118288
-
|
|
Parasite
|
Infection
|
|
Aurachin B is an alkaloid with a 3-hydroxyquinoline N-oxide core .
|
-
- HY-131578
-
-
- HY-145531
-
-
- HY-133728
-
-
- HY-N2561A
-
|
|
Others
|
Others
|
|
Spartioidine N-oxide is a pyrrolizidine alkaloid and can be isolated from Senecio vulgaris .
|
-
- HY-N3416
-
|
|
Others
|
Others
|
|
Koumine N-oxide is an alkaloid compound isolated from the herb Gelsemium elegans .
|
-
- HY-N6828
-
|
|
Others
|
Metabolic Disease
|
|
Monocrotaline N-Oxide, a monocrotaline metabolite, leads to DNA adduct formation in vivo .
|
-
- HY-Z19678A
-
|
trans-Haloperidol N-oxide
|
Drug Intermediate
|
Others
|
|
trans-Haloperidol impurity 7 (trans-Haloperidol N-oxide) is an impurity of trans-Haloperidol.
|
-
- HY-133797
-
|
|
Drug Metabolite
|
Neurological Disease
|
|
Cyclobenzaprine N-oxide is the tertiary amine metabolite of Cyclobenzaprine (HY-B0740) in liver particles. Cyclobenzaprine is a skeletal muscle relaxant and is active on the central nervous system. The liver cytosol from liver particles has reductase activity that can reduce Cyclobenzaprine N-oxide to the corresponding amine .
|
-
- HY-W703353
-
|
Trazodone 1,4-Di-N-oxide
|
Drug Intermediate
|
Others
|
|
Trazodone impurity 1 (Trazodone 1,4-Di-N-oxide) is an impurity of Trazodone.
|
-
- HY-N1105
-
|
|
Others
|
Others
|
|
Vallesamine N-oxide is a Alkaloids product that can be isolated from the leaves of Alstonia scholaris .
|
-
- HY-N8655
-
|
|
Others
|
Others
|
|
Sarracine N-oxide is a Alkaloids product that can be isolated from the herbs of Senecio scandens .
|
-
- HY-121414
-
|
Phenazine N-oxide; N-Oxyphenazine
|
Fungal
|
Infection
|
|
Phenazine oxide (Phenazine N-oxide) is a novel and potent fungicide, bactericide, and wood preservative .
|
-
- HY-G0011
-
-
- HY-131172
-
-
- HY-N9501
-
|
|
Others
|
Others
|
|
Retronecine N-oxide is a Alkaloids product that can be isolated from the roots of Arnebia euchroma .
|
-
- HY-101407
-
-
- HY-136487
-
|
Bu N-oxide
|
Drug Metabolite
|
Neurological Disease
|
|
Buspirone N-oxide (Bu N-oxide) is a metabolite of Buspirone (HY-B1115A). Buspirone is an orally active 5-HT1A receptor agonist, and a dopamine D2 autoreceptorsant antagonist. Buspirone is an anxiolytic agent, and can be used for the generalized anxiety disorder research .
|
-
- HY-134095
-
|
|
Drug Derivative
|
Infection
|
|
Erythromycin A N-oxide is a derivative of Erythromycin A and can be used in studies as a chiral selector in capillary electrophoresis .
|
-
- HY-N8965
-
|
|
Others
|
Others
|
|
Scandine N-oxide is a Alkaloids product that can be isolated from the dried herbs of Melodinus fusiformis. .
|
-
- HY-N6827
-
-
- HY-Z0833
-
-
- HY-100645
-
|
Trimethoprim 3-N-oxide
|
Drug Metabolite
|
Others
|
|
Trimethoprim 3-oxide (Trimethoprim 3-N-oxide) is the primary metabolite of trimethoprim .
|
-
- HY-W127785R
-
|
N,N-Dimethyldodecan-1-amine oxide (Standard); Dodecyldimethylamine oxide (Standard)
|
Biochemical Assay Reagents
Reference Standards
|
Others
|
|
N,N-Dimethyldodecylamine N-oxide (Standard) is the analytical standard of N-ethyl-N-oxido-dodecan-1-amine. This product is intended for research and analytical applications. N,N-Dimethyldodecylamine N-oxide is an amine oxide surfactant commonly used as a detergent, emulsifier and wetting agent in various industrial processes, especially in personal care products and household cleaning in the production of agents. N,N-Dimethyldodecylamine N-oxide has unique chemical properties that make it an effective ingredient in many product formulations to help reduce surface tension and enhance cleaning power.
|
-
- HY-N11812
-
|
|
Others
|
Metabolic Disease
|
|
Erucifoline N-oxide, a natural compound that can be isolated from Senecio persoonia, possesses hepatotoxic activity .
|
-
- HY-N8681
-
|
|
Others
|
Others
|
|
9-Angeloylretronecine N-oxide is a Alkaloids product that can be isolated from the roots of Arnebia euchroma .
|
-
- HY-134137
-
-
- HY-W701635
-
-
- HY-171000
-
-
- HY-133110
-
|
|
Drug Metabolite
|
Others
|
|
Afatinib N-Oxide is an impurity of Afatinib dimaleate in oxidative degradation. Afatinib dimaleate is an irreversible EGFR family inhibitor .
|
-
- HY-172560
-
-
- HY-105529
-
|
(+)-Indicine N-oxide; NSC 132319
|
Microtubule/Tubulin
|
Cancer
|
|
Indicine N-oxide (NSC 132319), a pyrrolizidine alkaloid, is an antitumor agent for pediatric cancer and solid tumors research .
|
-
- HY-N3104
-
|
Daphnilongeranine A N-oxide
|
Others
|
Others
|
|
Paxiphylline E (Daphnilongeranine A N-oxide) is a Alkaloids product that can be isolated from the mycelia of the basidiomycete Hericium erinaceum. .
|
-
- HY-W127785
-
|
N,N-Dimethyldodecan-1-amine oxide; Dodecyldimethylamine oxide
|
Environmental Pollutants
Biochemical Assay Reagents
|
Others
|
|
N,N-Dimethyldodecylamine N-oxide is an amine oxide surfactant commonly used as a detergent, emulsifier and wetting agent in various industrial processes, especially in personal care products and household cleaning in the production of agents. N,N-Dimethyldodecylamine N-oxide has unique chemical properties that make it an effective ingredient in many product formulations to help reduce surface tension and enhance cleaning power.
|
-
- HY-N9513
-
-
- HY-136428
-
|
|
Drug Metabolite
|
Cancer
|
|
Desoxycarbadox is a metabolite of Carbadox (HY-B1340). Carbadox is a quinoxaline-di-N-oxide antibiotic compound .
|
-
- HY-W653762
-
-
- HY-W653762A
-
-
- HY-133794
-
|
|
Drug Metabolite
|
Cancer
|
|
Dasatinib N-oxide is a minor metabolite of Dasatinib. Dasatinib is a potent and orally active dual Src/Bcr-Abl inhibitor .
|
-
- HY-100623
-
-
- HY-148846
-
|
|
Drug Metabolite
|
Metabolic Disease
|
|
Mosapride N-Oxide is a major active metabolite of Mosapride. Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
|
-
- HY-148376
-
|
|
Drug Metabolite
|
Cancer
|
|
Abiraterone N-oxide is a metabolite of Abiraterone (HY-148377). Abiraterone is a potent and irreversible CYP17A1 inhibitor with antiandrogen activity .
|
-
- HY-N8620
-
|
|
Others
|
Others
|
|
9-Methoxycanthin-6-one-N-oxide is a Alkaloids product that can be isolated from the barks of Ailanthus altissima .
|
-
- HY-B1340
-
-
- HY-N15616
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Parsonsine is ananalog of pyrrolizidine alkaloid that can be isolated in the N-oxide forms from adult bodies of the Apocynaceae-feeding danaine butterfly, Idea leuconoe .
|
-
- HY-175049
-
|
|
Endogenous Metabolite
|
Others
|
|
ALC-0315 N-oxide is an impurity of ALC-0315 ( HY-138170). ALC-0315 is an ionisable aminolipid for mRNA delivery .
|
-
- HY-W724128
-
|
|
Drug Derivative
|
Neurological Disease
|
|
Cariprazine N-oxide (Compound DP-3) is the mono-oxidative degradation product of Cariprazine hydrochloride (HY-14763A). Cariprazine hydrochloride exhibits antipsychotic activity .
|
-
- HY-W354971
-
-
- HY-133795
-
|
|
DNA/RNA Synthesis
|
Others
|
|
Lucanthone N-oxide is the nitrogen oxide of Lucanthone (HY-B2098), an endonuclease inhibitor of Apurinic endonuclease-1 (APE-1) .
|
-
- HY-130318
-
-
- HY-43421
-
|
Solifenacin N1-oxide
|
mAChR
|
Neurological Disease
|
|
Solifenacin N-oxide (Solifenacin N1-oxide) is an inactive metabolite of the muscarinic receptor antagonist Solifenacin (HY-A0034) .
|
-
- HY-W127842
-
|
Decyldimethylamine oxide
|
Biochemical Assay Reagents
|
Others
|
|
N,N-Dimethyldecylamine N-oxide is an organic compound belonging to the family of amine oxides. It is commonly used as a surfactant and cleaning agent in a variety of industrial and household applications, including detergents, personal care products and paints. N,N-Dimethyldecylamine N-oxide has various properties suitable for these applications, including the ability to lower surface tension, increase solubility, and act as a blowing agent. In addition, it can be used as a corrosion inhibitor in metalworking fluids and a flotation agent in mineral processing.
|
-
- HY-133790
-
-
- HY-136428S
-
|
|
Isotope-Labeled Compounds
|
Cancer
|
|
Desoxycarbadox-d3 is the deuterium labeled Desoxycarbadox. Desoxycarbadox is a metabolite of Carbadox (HY-B1340). Carbadox is a quinoxaline-di-N-oxide antibiotic compound.
|
-
- HY-14538S2
-
-
- HY-Z4690
-
-
- HY-129130
-
|
Canthin-6-one 3-oxide
|
Parasite
|
Infection
|
|
Canthin-6-one N-oxide (Canthin-6-one 3-oxide) is an orally active antiparasitic agent with limited activity .
|
-
- HY-N8723
-
|
|
Others
|
Neurological Disease
|
|
(1′S,2′S)-Nicotine-1'-oxide is an alkaloid N-oxide from the leaves, stems and roots of Nicotiana tabacum .
|
-
- HY-W099730
-
|
Tinosorb S
|
Others
|
Others
|
|
Bemotrizinol (Tinosorb S), a compound that can absorb ultraviolet light, has been shown to accept atomic oxygen generated by N-oxide photodeoxygenation .
|
-
- HY-135742
-
|
Lenvatinib impurity 10
|
VEGFR
|
Cancer
|
|
Lenvatinib N-Oxide (Lenvatinib impurity 10) is the impurity of Lenvatinib (HY-10981). Lenvatinib (E7080) is an orally active, multi-targeted tyrosine kinase inhibitor .
|
-
- HY-114202S
-
-
- HY-B1340S
-
|
|
Bacterial
Antibiotic
Endogenous Metabolite
|
Infection
|
|
Carbadox-d3 is the deuterium labeled Carbadox. Carbadox is a quinoxaline-di-N-oxide antibiotic compound which is widely fed to nursery-age pigs to control enteric diseases and improve feed efficiency.
|
-
- HY-133772
-
|
|
Drug Metabolite
|
Others
|
|
Venetoclax N-oxide is an impurity of Venetoclax. Venetoclax (ABT-199; GDC-0199) is a highly potent, selective and orally bioavailable Bcl-2 inhibitor with a Ki of less than 0.01 nM .
|
-
- HY-121390A
-
|
|
Endogenous Metabolite
|
Cancer
|
|
Lasiocarpine hydrochloride, a hepatotoxic pyrrolizidine alkaloid (PA), causes fatal liver veno-occlusive disease in vivo. Lasiocarpine hydrochloride is toxic only after its metabolic conversion to the toxic intermediate, including dehydrolasiocarpine and N-oxide .
|
-
- HY-136428R
-
|
|
Drug Metabolite
Antibiotic
Reference Standards
|
Cancer
|
|
Desoxycarbadox (Standard) is the analytical standard of Desoxycarbadox. This product is intended for research and analytical applications. Desoxycarbadox is a metabolite of Carbadox (HY-B1340). Carbadox is a quinoxaline-di-N-oxide antibiotic compound .
|
-
- HY-121390
-
|
|
Endogenous Metabolite
|
Cancer
|
|
Lasiocarpine, a hepatotoxic pyrrolizidine alkaloid (PA), causes fatal liver veno-occlusive disease in vivo. Lasiocarpine is toxic only after its metabolic conversion to the toxic intermediate, including dehydrolasiocarpine and N-oxide .
|
-
- HY-N16484
-
|
|
Others
|
Others
|
|
Trichodesmine N-oxide is the oxidized form of a pyrrolizidine alkaloid (PA) that can be isolated from the sunn hemp (Crotalaria juncea) teas. PAs are secondary metabolites in plants, which may exhibit toxicity and carcinogenicity .
|
-
- HY-W746075A
-
|
|
mAChR
|
Neurological Disease
|
|
(±)-Darifenacin N-Oxide is the impurity of Darifenacin (HY-A0033). Darifenacin (UK-88525) is a selective and orally active M3 muscarinic receptor (M3R) antagonist with a pKi of 8.9 .
|
-
- HY-W099730R
-
|
Tinosorb S (Standard)
|
Reference Standards
Others
|
Others
|
|
Bemotrizinol (Standard) is the analytical standard of Bemotrizinol. This product is intended for research and analytical applications. Bemotrizinol (Tinosorb S), an ultraviolet (UV) filter, has been shown to accept atomic oxygen generated by N-oxide photodeoxygenation .
|
-
- HY-W700867
-
-
- HY-W016099
-
|
MQCA
|
Drug Metabolite
|
Cancer
|
|
3-Methyl-2-quinoxalinecarboxylic acid (MQCA), an important N-oxide reductive metabolite of Quinocetone or Olaquindox, potently inhibits the growth of Chang liver cells through S phase arrest of the cell cycle .
|
-
- HY-B1340R
-
|
|
Reference Standards
Bacterial
Antibiotic
Endogenous Metabolite
|
Infection
|
|
Carbadox (Standard) is the analytical standard of Carbadox. This product is intended for research and analytical applications. Carbadox is a quinoxaline-di-N-oxide antibiotic compound which is widely fed to nursery-age pigs to control enteric diseases and improve feed efficiency.
|
-
- HY-120976
-
|
|
Biochemical Assay Reagents
|
Cancer
|
|
cDEPMPO is a potent anticancer proagent. High concentrations of DEPMPO spin-trap the ·OH radical together with aryl radicals arising from one-electron reduced BTO (benzotriazine 1,4-di-N-oxide) compounds .
|
-
- HY-W742574
-
|
|
Isotope-Labeled Compounds
|
Others
|
|
Venlafaxine N-Oxide-d6-1 is the deuterium labeled 2-(1-Hydroxycyclohexyl)-2-(4-methoxyphenyl)-N,N-dimethylethan-1-amine oxide (HY-W704254).
|
-
- HY-135408
-
|
|
Drug Metabolite
|
Cardiovascular Disease
Inflammation/Immunology
|
|
Trimetazidine-N-oxide is the major active metabolite of Trimetazidine. Trimetazidine is a selective long chain 3-ketoyl coenzyme A thiolase inhibitor with an IC50 of 75 nM. Trimetazidine is an effective antianginal agent, has anti-oxidant, anti-inflammatory, antinociceptive and gastroprotective properties.
|
-
- HY-133716
-
|
|
Drug Intermediate
|
Inflammation/Immunology
|
|
Pantoprazole N-oxide (Impurity-VI) is the impurity found during the Pantoprazole (HY-17507) production. Pantoprazole is an inhibitor for proton pump (PPI) that can be used for diseases related to excessive gastric acid, such as gastric ulcers and gastroesophageal reflux disease (GERD) .
|
-
- HY-131254
-
|
|
Drug Metabolite
|
Neurological Disease
|
|
(S)-O-Desmethyl Venlafaxine N-Oxide is a N-oxyde of (S)-O-Desmethyl Venlafaxine. O-Desmethyl Venlafaxine is an active metabolite of Venlafaxine . Venlafaxine (HY-B0196) is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class .
|
-
- HY-W127785S
-
|
N,N-Dimethyldodecylamine N-oxide-d31; Dodecyldimethylamine oxide-d31
|
Isotope-Labeled Compounds
|
Others
|
|
N-Ethyl-N-oxido-dodecan-1-amine-d31 (N,N-Dimethyldodecylamine N-oxide-d31) is the deuterium labeled N-Ethyl-N-oxido-dodecan-1-amine. N-ethyl-N-oxido-dodecan-1-amine is an amine oxide surfactant commonly used as a detergent, emulsifier and wetting agent in various industrial processes, especially in personal care products and household cleaning in the production of agents. N,N-Dimethyldodecylamine N-oxide has unique chemical properties that make it an effective ingredient in many product formulations to help reduce surface tension and enhance cleaning power.
|
-
- HY-125309
-
|
|
Platelet-activating Factor Receptor (PAFR)
|
Others
|
|
ABT-299 is a prodrug of a platelet-activating factor (PAF) antagonist that exhibits significant inhibitory activity on PAF-induced β-platelet globulin release in vitro after in vivo administration in humans, an effect that may be partially attributed to the pyridine-N-oxide metabolite.
|
-
- HY-14545S1
-
-
- HY-135740
-
-
- HY-W585873
-
|
|
Drug Metabolite
|
Metabolic Disease
|
|
Bupivacaine N-oxide hydrochloride is a metabolite of Bupivacaine (HY-B0405). Bupivacaine is a NMDA receptor inhibitor. Bupivacaine can block sodium, L-calcium, and potassium channels.Bupivacaine potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine can be used for the research of chronic pain.
|
-
- HY-W741847
-
|
|
Isotope-Labeled Compounds
|
Others
|
|
Tapentadol N-Oxide-d5 is the deuterium labeled (2R,3R)-3-(3-Hydroxyphenyl)-N,N,2-trimethylpentan-1-amine oxide (HY-W703015).
|
-
- HY-169466
-
|
|
Drug Derivative
|
Neurological Disease
|
|
5-Methoxy-N,N-dimethyltryptamine Nb-oxide is an indole alkaloid. 5-Methoxy-N,N-dimethyltryptamine Nb-oxide is the N-oxide form of 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), which is a known psychoactive substance .
|
-
- HY-12987S1
-
-
- HY-W016099S
-
|
MQCA-d4
|
Isotope-Labeled Compounds
|
Cancer
|
|
3-Methyl-2-quinoxalinecarboxylic acid-d4 is the deuterium labeled 3-Methyl-2-quinoxalinecarboxylic acid. 3-Methyl-2-quinoxalinecarboxylic acid (MQCA), an important N-oxide reductive metabolite of Quinocetone or Olaquindox, potently inhibits the growth of Chang liver cells through S phase arrest of the cell cycle .
|
-
- HY-W016099R
-
|
MQCA (Standard)
|
Drug Metabolite
Reference Standards
|
Cancer
|
|
3-Methyl-2-quinoxalinecarboxylic acid (Standard) is the analytical standard of 3-Methyl-2-quinoxalinecarboxylic acid. This product is intended for research and analytical applications. 3-Methyl-2-quinoxalinecarboxylic acid (MQCA), an important N-oxide reductive metabolite of Quinocetone or Olaquindox, potently inhibits the growth of Chang liver cells through S phase arrest of the cell cycle .
|
-
- HY-15455S1
-
|
|
Phosphodiesterase (PDE)
RSV
|
Inflammation/Immunology
|
|
Roflumilast-d4 N-Oxide is the deuterium labeled Roflumilast. Roflumilast is a selective PDE4 inhibitor with IC50s of 0.7, 0.9, 0.7, and 0.2 nM for PDE4A1, PDEA4, PDEB1, and PDEB2, respectively, without affecting PDE1, PDE2, PDE3 or PDE5 isoenzymes from various cells .
|
-
- HY-B0185S
-
|
|
Isotope-Labeled Compounds
Sodium Channel
MEK
ERK
NF-κB
Apoptosis
|
Cardiovascular Disease
Cancer
|
|
N-Oxide Lidocaine-d10 is the deuterium labeled Lidocaine. Lidocaine (Lignocaine) inhibits sodium channels involving complex voltage and using dependence . Lidocaine decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine is an amide derivative and has potential for the research of ventricular arrhythmia .
|
-
- HY-130059
-
|
Guanine 7-N-oxide
|
Antibiotic
Fungal
HSV
|
Infection
Cancer
|
|
Guanine-7-oxide (Guanine 7-N-oxide) is an antitumor antibiotic with anti-tumor, anti-Candida albicans activity, and can inhibit viral replication effect of herpes virus, infectious blood virus (IHNV), infectious pancreatic necrosis virus (IPNV) and so on. Guanine-7-oxide has good activity against mouse L1210 leukemia cells .
|
-
- HY-D3377
-
|
LysoRhoNox
|
Fluorescent Dye
|
Others
|
|
HMRhoNox-M (LysoRhoNox) is a selective fluorescent probe for labile Fe 2+ with an orange fluorescence, and its excitation/emission wavelength is λₑₓ/λₑₘ = 555/575 nm. HMRhoNox-M undergoes N-oxide deoxygenation mediated by Fe 2+, converting from a non-fluorescent spirocyclic closed form to a fluorescent quinone open form. HMRhoNox-M is used to detect labile Fe 2+ in living cells .
|
-
- HY-D2339
-
|
|
Fluorescent Dye
|
Others
|
|
H-FluNox is a selective fluorescent probe that senses labile heme using biomimetic N-oxide deoxygenation to trigger fluorescence. H-FluNox is more than 100-fold selective for labile heme over Fe(II), enabling the discrimination of labile heme from labile Fe(II) pools in living cells. H-FluNox is sensitive enough to detect the subcellular labile heme. (λex=490 nm, λem=535 nm)
|
-
- HY-W012977
-
-
- HY-W710279
-
|
|
Isotope-Labeled Compounds
Biochemical Assay Reagents
|
Others
|
|
N-ethyl-N-oxido-dodecan-1-amine-d6 is the deuterium labeled N-ethyl-N-oxido-dodecan-1-amine (HY-W127785). N-ethyl-N-oxido-dodecan-1-amine is an amine oxide surfactant commonly used as a detergent, emulsifier and wetting agent in various industrial processes, especially in personal care products and household cleaning in the production of agents. N,N-Dimethyldodecylamine N-oxide has unique chemical properties that make it an effective ingredient in many product formulations to help reduce surface tension and enhance cleaning power.
|
-
- HY-W012977R
-
-
| Cat. No. |
Product Name |
Type |
-
- HY-D2339
-
|
|
Fluorescent Dyes
|
|
H-FluNox is a selective fluorescent probe that senses labile heme using biomimetic N-oxide deoxygenation to trigger fluorescence. H-FluNox is more than 100-fold selective for labile heme over Fe(II), enabling the discrimination of labile heme from labile Fe(II) pools in living cells. H-FluNox is sensitive enough to detect the subcellular labile heme. (λex=490 nm, λem=535 nm)
|
-
- HY-D3377
-
|
LysoRhoNox
|
Fluorescent Dyes
|
|
HMRhoNox-M (LysoRhoNox) is a selective fluorescent probe for labile Fe 2+ with an orange fluorescence, and its excitation/emission wavelength is λₑₓ/λₑₘ = 555/575 nm. HMRhoNox-M undergoes N-oxide deoxygenation mediated by Fe 2+, converting from a non-fluorescent spirocyclic closed form to a fluorescent quinone open form. HMRhoNox-M is used to detect labile Fe 2+ in living cells .
|
| Cat. No. |
Product Name |
Type |
-
- HY-W127785
-
|
N,N-Dimethyldodecan-1-amine oxide; Dodecyldimethylamine oxide
|
Biochemical Assay Reagents
|
|
N,N-Dimethyldodecylamine N-oxide is an amine oxide surfactant commonly used as a detergent, emulsifier and wetting agent in various industrial processes, especially in personal care products and household cleaning in the production of agents. N,N-Dimethyldodecylamine N-oxide has unique chemical properties that make it an effective ingredient in many product formulations to help reduce surface tension and enhance cleaning power.
|
-
- HY-W127842
-
|
Decyldimethylamine oxide
|
Biochemical Assay Reagents
|
|
N,N-Dimethyldecylamine N-oxide is an organic compound belonging to the family of amine oxides. It is commonly used as a surfactant and cleaning agent in a variety of industrial and household applications, including detergents, personal care products and paints. N,N-Dimethyldecylamine N-oxide has various properties suitable for these applications, including the ability to lower surface tension, increase solubility, and act as a blowing agent. In addition, it can be used as a corrosion inhibitor in metalworking fluids and a flotation agent in mineral processing.
|
-
- HY-W127785R
-
|
N,N-Dimethyldodecan-1-amine oxide (Standard); Dodecyldimethylamine oxide (Standard)
|
Biochemical Assay Reagents
|
|
N,N-Dimethyldodecylamine N-oxide (Standard) is the analytical standard of N-ethyl-N-oxido-dodecan-1-amine. This product is intended for research and analytical applications. N,N-Dimethyldodecylamine N-oxide is an amine oxide surfactant commonly used as a detergent, emulsifier and wetting agent in various industrial processes, especially in personal care products and household cleaning in the production of agents. N,N-Dimethyldodecylamine N-oxide has unique chemical properties that make it an effective ingredient in many product formulations to help reduce surface tension and enhance cleaning power.
|
| Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
- HY-N17527
-
-
- HY-N17304
-
-
- HY-N13343
-
-
- HY-N1105
-
-
- HY-N8655
-
-
- HY-N3104
-
-
- HY-W012977R
-
-
| Cat. No. |
Product Name |
Chemical Structure |
-
- HY-116084S
-
1 Publications Verification
|
|
Trimethylamine N-oxide-d9 is the deuterium labeled Trimethylamine N-oxide. Trimethylamine N-oxide is a gut microbe-dependent metabolite of dietary choline and other trimethylamine-containing nutrients. Trimethylamine N-oxide induces inflammation by activating the ROS/NLRP3 inflammasome. Trimethylamine N-oxide also accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis by activating the TGF-β/smad2 signaling pathway .
|
-
-
- HY-114202S
-
2 Publications Verification
|
|
delta-Valerobetaine-d9 chloride is the deuterium labeled delta-Valerobetaine (HY-114202) . delta-Valerobetaine is a precursor of trimethylamine N-oxide (TMAO) .
|
-
-
- HY-N6637S
-
|
|
|
Senecionine N-oxide-d3 is the deuterium labeled Senecionine N-oxide. Senecionine n-oxide is the primary product of pyrrolizidine alkaloid biosynthesis in root cultures of Senecio vulgaris. Senecionine N-oxide has anti-cancer activity .
|
-
-
- HY-116084S1
-
|
|
|
Trimethylamine-N-oxide- 13C3 is the 13C-labeled Trimethylamine N-oxide. Trimethylamine N-oxide is a gut microbe-dependent metabolite of dietary choline and other trimethylamine-containing nutrients. Trimethylamine N-oxide induces inflammation by activating the ROS/NLRP3 inflammasome. Trimethylamine N-oxide also accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis by activating the TGF-β/smad2 signaling pathway .
|
-
-
- HY-W016099S
-
|
|
|
3-Methyl-2-quinoxalinecarboxylic acid-d4 is the deuterium labeled 3-Methyl-2-quinoxalinecarboxylic acid. 3-Methyl-2-quinoxalinecarboxylic acid (MQCA), an important N-oxide reductive metabolite of Quinocetone or Olaquindox, potently inhibits the growth of Chang liver cells through S phase arrest of the cell cycle .
|
-
-
- HY-141773S
-
|
|
|
Benzydamine N-oxide-d6 is the deuterium labeled Benzydamine N-oxide .
|
-
-
- HY-133794S
-
|
|
|
Dasatinib N-oxide-d8 is the deuterium labeled Dasatinib N-oxide. Dasatinib N-oxide is a minor metabolite of Dasatinib. Dasatinib is a potent and orally active dual Src/Bcr-Abl inhibitor .
|
-
-
- HY-W700973S
-
|
|
|
Chlorpheniramine N-oxide-d6 is the deuterium labeled Chlorpheniramine N-oxide.
|
-
-
- HY-146481S
-
|
|
|
Lansoprazole sulfone N-oxide-d4 is the deuterium labeled Lansoprazole sulfone N-oxide .
|
-
-
- HY-138199S
-
|
|
|
Omeprazole sulfone N-oxide- 13C,d3 is the deuterium and 13C labeled Omeprazole sulfone N-Oxide .
|
-
-
- HY-W700867
-
|
|
|
Alpha-Carboline N-Oxide- 15N2 is the 15N labeled 9H-Pyrido[2,3-b]indole 1-oxide (HY-W700873).
|
-
-
- HY-12987S1
-
|
|
|
Pimozide-d5 N-Oxide is the deuterium labeled Pimozide. Pimozide is a dopamine receptor antagonist, with Kis of 1.4 nM, 2.5 nM and 588 nM for dopamine D2, D3 and D1 receptors, respectively, and also has affinity at α1-adrenoceptor, with a Ki of 39 nM; Pimozide also inhibits STAT3 and STAT5 .
|
-
-
- HY-B0185S
-
|
|
|
N-Oxide Lidocaine-d10 is the deuterium labeled Lidocaine. Lidocaine (Lignocaine) inhibits sodium channels involving complex voltage and using dependence . Lidocaine decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine is an amide derivative and has potential for the research of ventricular arrhythmia .
|
-
-
- HY-N9512S
-
|
|
|
Lycopsamine N-oxide-d3 is the deuterium labeled Lycopsamine N-oxide. Lycopsamine N-oxide, an N-oxide of Lycopsamine which is a pyrrolizidine alkaloid, can be found in honey and bee pollen .
|
-
-
- HY-137989S
-
|
|
|
Voriconazole N-oxide-d3 (Voriconazole oxynitride-d3) is deuterium labeled Voriconazole N-oxide. Voriconazole N-oxide (Voriconazole oxynitride) is a potent antifungal agent. Voriconazole N-oxide has phototoxicity and photocarcinogenicity. Voriconazole N-oxide does not sensitize keratinocytes to ultraviolet B (UVB) .
|
-
-
- HY-W740127
-
|
|
|
Quinidine-d3 N-Oxide is the deuterium labeled Quinidine N-Oxide.
|
-
-
- HY-134137S
-
|
|
|
Donepezil N-oxide-d5 is deuterium labeled Donepezil N-oxide.
|
-
-
- HY-W769381
-
|
|
|
Lycopsamine N-oxide-d7 is deuterium labeled Lycopsamine N-oxide .
|
-
-
- HY-144239S
-
|
|
|
Venlafaxine N-oxide-d6 is the deuterium labeled Venlafaxine N-oxide .
|
-
-
- HY-135740S
-
|
|
|
Diphenhydramine N-?Oxide-d6 is the deuterium labeled Diphenhydramine N-?Oxide .
|
-
-
- HY-W701397
-
|
|
|
Nicotinamide N-oxide-d4 is the deuterium labeled Nicotinamide N-oxide (HY-101407). Nicotinamide N-oxide, an in vivo nicotinamide metabolite, is a potent, and selective antagonist of the CXCR2 receptor.
|
-
-
- HY-W709612
-
|
|
|
Regorafenib N-oxide and N-desmethyl (M5)-d3-1 (N-Desmethyl regorafenib N-oxide-d3-1) is the deuterium labeled Regorafenib N-oxide and N-desmethyl (M5) (HY-108226). Regorafenib N-oxide and N-desmethyl (M5) (N-Desmethyl regorafenib N-oxide) is an active metabolite of Sorafenib (HY-10201) and can be metabolized by CYP3A4 .
|
-
-
- HY-G0011S
-
|
|
|
Netupitant N-oxide-d6 is the deuterium labeled Netupitant N-oxide, which is a metabolite of Netupitant.
|
-
-
- HY-138199S1
-
|
|
|
Omeprazole sulfone N-oxide-d3 is the deuterium labeled Omeprazole sulfone N-Oxide .
|
-
-
- HY-W753452
-
|
|
|
N,N-Dimethyltryptamine N-oxide-d6 is the deuterium labeled N,N-Dimethyltryptamine N-oxide (HY-W576312). N,N-Dimethyltryptamine N-oxide is a metabolite of N,N-Dimethyltryptamine .
|
-
-
- HY-W739718
-
|
|
|
(R,S)-Cotinine-d3 N-Oxide is the deuterium labeled (R,S)-Cotinine N-Oxide.
|
-
-
- HY-142440S
-
|
|
|
Apatinib 25-N-oxide-d8 (dihydrochloride) is the deuterium labeled Apatinib 25-N-oxide dihydrochloride .
|
-
-
- HY-W748582
-
|
|
|
Clozapine N-oxide-d8 is the deuterium labeled Clozapine N-oxide (HY-17366). Clozapine N-oxide is a major metabolite of Clozapine and a human muscarinic designer receptors (DREADDs) agonist. Clozapine N-oxide activates the DREADD receptor hM3Dq and hM4Di. Clozapine N-oxide can't cross the blood-brain barrier . Clozapine is a potent dopamine antagonist and also a potent and selective muscarinic M4 receptor (EC50=11 nM) agonist .
|
-
-
- HY-W722562
-
|
|
|
Trimethylamine oxide- 15N is the deuterium labeled Trimethylamine N-oxide (HY-116084). Trimethylamine N-oxide is a gut microbe-dependent metabolite of dietary choline and other trimethylamine-containing nutrients. Trimethylamine N-oxide induces inflammation by activating the ROS/NLRP3 inflammasome. Trimethylamine N-oxide also accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis by activating the TGF-β/smad2 signaling pathway .
|
-
-
- HY-108226S
-
|
|
|
Regorafenib N-oxide and N-desmethyl (M5)-d3 is deuterium labeled Regorafenib N-oxide and N-desmethyl (M5).
|
-
-
- HY-108226S1
-
|
|
|
Regorafenib N-oxide and N-desmethyl (M5)- 13C6 is the 13C-labeled Regorafenib N-oxide and N-desmethyl (M5) .
|
-
-
- HY-136428S
-
1 Publications Verification
|
|
Desoxycarbadox-d3 is the deuterium labeled Desoxycarbadox. Desoxycarbadox is a metabolite of Carbadox (HY-B1340). Carbadox is a quinoxaline-di-N-oxide antibiotic compound.
|
-
-
- HY-14538S2
-
|
|
|
Haloperidol-d4 N-Oxide is the deuterium labeled Haloperidol. Haloperidol is a potent dopamine D2 receptor antagonist, widely used as an antipsychotic .
|
-
-
- HY-B1340S
-
|
|
|
Carbadox-d3 is the deuterium labeled Carbadox. Carbadox is a quinoxaline-di-N-oxide antibiotic compound which is widely fed to nursery-age pigs to control enteric diseases and improve feed efficiency.
|
-
-
- HY-14545S1
-
|
|
|
Amisulpride-d5 N-Oxide is the deuterium labeled Amisulpride. Amisulpride is a dopamine D2/D3 receptor antagonist with Kis of 2.8 and 3.2 nM for human dopamine D2 and D3, respectively .
|
-
-
- HY-W741847
-
|
|
|
Tapentadol N-Oxide-d5 is the deuterium labeled (2R,3R)-3-(3-Hydroxyphenyl)-N,N,2-trimethylpentan-1-amine oxide (HY-W703015).
|
-
-
- HY-15455S1
-
|
|
|
Roflumilast-d4 N-Oxide is the deuterium labeled Roflumilast. Roflumilast is a selective PDE4 inhibitor with IC50s of 0.7, 0.9, 0.7, and 0.2 nM for PDE4A1, PDEA4, PDEB1, and PDEB2, respectively, without affecting PDE1, PDE2, PDE3 or PDE5 isoenzymes from various cells .
|
-
-
- HY-W710279
-
|
|
|
N-ethyl-N-oxido-dodecan-1-amine-d6 is the deuterium labeled N-ethyl-N-oxido-dodecan-1-amine (HY-W127785). N-ethyl-N-oxido-dodecan-1-amine is an amine oxide surfactant commonly used as a detergent, emulsifier and wetting agent in various industrial processes, especially in personal care products and household cleaning in the production of agents. N,N-Dimethyldodecylamine N-oxide has unique chemical properties that make it an effective ingredient in many product formulations to help reduce surface tension and enhance cleaning power.
|
-
-
- HY-W698938
-
|
|
|
Pyridine N-oxide-d5 is the deuterium labeled Pyridine N-oxide.
|
-
-
- HY-W703386
-
|
|
|
Bupivacaine-d9 N-Oxide is the deuterium labeled Bupivacaine N-Oxide.
|
-
-
- HY-133786S
-
|
|
|
Clemastine N-oxide-d5 is the deuterium labeled Clemastine N-oxide.
|
-
-
- HY-W710291
-
|
|
|
Rivastigmine N-oxide-d6 is the deuterium labeled Rivastigmine N-oxide.
|
-
-
- HY-119393S
-
|
|
|
Olanzapine N-Oxide-d3 is a deuterated labeled Olanzapine N-Oxide .
|
-
-
- HY-132447S
-
|
|
|
Nefopam-d3 N-Oxide is the deuterium labeled Nefopam N-Oxide .
|
-
-
- HY-141783S
-
|
|
|
Clomipramine N-Oxide-d6 is the deuterium labeled Clomipramine N-Oxide .
|
-
-
- HY-133797S
-
|
|
|
Cyclobenzaprine N-oxide-d3 is the deuterium labeled Cyclobenzaprine N-oxide .
|
-
-
- HY-133792S
-
|
|
|
Olopatadine-d3 N-Oxide is the deuterium labeled Olopatadine N-Oxide .
|
-
-
- HY-W087967S
-
|
|
|
4-Nitropyridine N-oxide-d4 is the deuterium labeled 4-Nitropyridine N-oxide .
|
-
-
- HY-132343S
-
|
|
|
Zolmitriptan N-Oxide-d6 is a deuterium labeled Zolmitriptan N-Oxide. Zolmitriptan N-Oxide is the major metabolite of Zolmitriptan. Zolmitriptan is a 5-HT1B/1D receptor partial agonist .
|
-
-
- HY-W742574
-
|
|
|
Venlafaxine N-Oxide-d6-1 is the deuterium labeled 2-(1-Hydroxycyclohexyl)-2-(4-methoxyphenyl)-N,N-dimethylethan-1-amine oxide (HY-W704254).
|
-
- HY-W127785S
-
|
|
|
N-Ethyl-N-oxido-dodecan-1-amine-d31 (N,N-Dimethyldodecylamine N-oxide-d31) is the deuterium labeled N-Ethyl-N-oxido-dodecan-1-amine. N-ethyl-N-oxido-dodecan-1-amine is an amine oxide surfactant commonly used as a detergent, emulsifier and wetting agent in various industrial processes, especially in personal care products and household cleaning in the production of agents. N,N-Dimethyldodecylamine N-oxide has unique chemical properties that make it an effective ingredient in many product formulations to help reduce surface tension and enhance cleaning power.
|
-
| Cat. No. |
Product Name |
|
Classification |
-
- HY-158815
-
|
Lipid H N-Oxide; LNP-102 N-Oxide
|
|
Cationic Lipids
|
|
SM-102 N-oxide (Lipid H N-Oxide) is an impurity of SM-102 (HY-134541).
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: